SFM
MRVI icon

Systematic Financial Management’s Maravai LifeSciences MRVI Stock Holding History

Systematic Financial Management’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.4M Buy
1,665,817
+181,278
+12% +$783K 0.21% 144
2026
Q1 		$4.2M Sell
1,484,539
-35,781
-2% -$121K 0.1% 168
2025
Q4 		$4.94M Sell
1,520,320
-2,471
-0.2% -$8.32K 0.12% 159
2025
Q3 		$4.37M Sell
1,522,791
-148,926
-9% -$380K 0.11% 156
2025
Q2 		$4.03M Buy
1,671,717
+135,534
+9% +$285K 0.11% 159
2025
Q1 		$3.39M Sell
1,536,183
-113,361
-7% -$448K 0.1% 163
2024
Q4 		$8.99M Buy
1,649,544
+37,383
+2% +$241K 0.23% 132
2024
Q3 		$13.4M Buy
1,612,161
+206,499
+15% +$1.79M 0.34% 119
2024
Q2 		$10.1M Sell
1,405,662
-99,491
-7% -$859K 0.31% 124
2024
Q1 		$13M Buy
1,505,153
+180,832
+14% +$1.22M 0.36% 114
2023
Q4 		$8.67M Buy
1,324,321
+150,234
+13% +$971K 0.26% 133
2023
Q3 		$11.7M Buy
1,174,087
+64,472
+6% +$708K 0.38% 110
2023
Q2 		$13.8M Buy
1,109,615
+322,878
+41% +$4.36M 0.44% 105
2023
Q1 		$11M Buy
786,737
+62,991
+9% +$905K 0.36% 116
2022
Q4 		$10.4M Buy
+723,746
New +$11.4M 0.34% 120

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Systematic Financial Management's MRVI Position: Q2 2026 in Review

Systematic Financial Management increased its Maravai LifeSciences (MRVI) stake by 12% in Q2 2026, buying an estimated $783K and bringing the position to 1,665,817 shares worth $10.4M. The position accounts for 0.21% of the portfolio, ranked #144.

Systematic Financial Management first reported a position in MRVI in Q4 2022 and has held it in 15 quarters since. The position peaked at $13.8M in Q2 2023. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • Systematic Financial Management held 1,665,817 shares of Maravai LifeSciences worth $10.4M as of Q2 2026.
  • Systematic Financial Management bought 181,278 Maravai LifeSciences shares in Q2 2026, an estimated $783K.
  • Maravai LifeSciences made up 0.21% of Systematic Financial Management's portfolio in Q2 2026, its #144 holding.
  • Systematic Financial Management first reported a position in Maravai LifeSciences in Q4 2022 and has held it in 15 quarters since.
  • Systematic Financial Management's Maravai LifeSciences position peaked at $13.8M in Q2 2023.
  • 178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Systematic Financial Management's 13F filing for Q2 2026, filed 14 Aug 2026.